Characteristics and Prognosis of Microscopic Polyangiitis Patients with Diffuse Alveolar Hemorrhage and Interstitial

Yu Gu1, Ting Zhang1, Min Peng1

  • 1Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, China.

Insights

Microscopic polyangiitis (MPA) patients with diffuse alveolar hemorrhage (DAH) and interstitial lung disease (ILD) show distinct clinical features and prognoses. DAHILD patients face the highest mortality, highlighting the need for subtype-specific research.

Area of Science:

  • Pulmonary Medicine
  • Rheumatology
  • Clinical Research

Background:

  • Microscopic polyangiitis (MPA) can manifest with diverse pulmonary involvements, including diffuse alveolar hemorrhage (DAH) and interstitial lung disease (ILD).
  • Understanding the distinct clinical characteristics and prognostic factors of these MPA-related pulmonary subtypes is crucial for patient management.

Purpose of the Study:

  • To evaluate the clinical features and identify prognostic predictors for MPA patients with DAH and/or ILD.
  • To differentiate between DAH, ILD, and combined DAH and ILD (DAHILD) pulmonary involvement patterns in MPA.

Main Methods:

  • Retrospective review of medical records of 181 newly diagnosed MPA patients (2002-2012).
  • Classification into ILD, DAH, DAHILD, and no pulmonary involvement (NPI) groups.
  • Analysis of clinical characteristics and identification of short-term and long-term death risk factors using logistic regression and Cox analysis.

Main Results:

  • The DAH group exhibited significantly higher serum creatinine levels than ILD and DAHILD groups.
  • Patients in the ILD group were older than those in the DAH group.
  • The DAHILD group had the highest mortality (72.2%).
  • Elevated white blood cell count predicted short-term death.
  • Old age, cardiovascular involvement, and poor renal function predicted long-term death.
  • Pulmonary infections were the leading cause of death, particularly in ILD patients.

Conclusions:

  • MPA patients with different pulmonary involvement patterns (DAH, ILD, DAHILD) exhibit distinct clinical features and prognoses.
  • These subtypes may arise from different pathogenetic mechanisms, necessitating separate investigation.
  • Identifying specific risk factors for mortality in each subtype is essential for targeted interventions.